The Miami Entrepreneur

Earnings Results: Amgen’s Q4 tops views, but 2023 guidance falls on lower end of expectations

Read Time:9 Second

Amgen Inc. topped Wall Street expectations for its fourth quarter, but the drug maker’s shares fell after hours as its 2023 guidance fell on the lower end of Wall Street’s expectations.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Deep Dive: These 20 stocks led the January rally
Next post Milton Keynes: Four-year-old girl killed in dog attack